Company Filing History:
Years Active: 1992-2005
Title: The Innovative Contributions of Gareth Lewis
Introduction
Gareth Lewis is a notable inventor based in Dourdan, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing advanced drug delivery systems that enhance the efficacy and safety of medications.
Latest Patents
One of Gareth Lewis's latest patents is a pharmaceutical composition with gastric residence and controlled release. This invention is characterized by its unique structure, which comprises two or three layers. It includes an active principle associated with an excipient that modifies its release, along with a system that generates carbon dioxide in a swelling polymer hydrophilic matrix. These components can be included in a common layer or in separate layers, providing innovative solutions for drug delivery.
Another significant patent relates to controlled-release dosage forms comprising zolpidem or a salt thereof. This invention is designed to release zolpidem over a predetermined time period, following a biphasic profile of dissolution. The first phase is an immediate release phase, while the second phase is a prolonged release phase. This design aims to avoid potential abuse of the medication, showcasing Lewis's commitment to patient safety.
Career Highlights
Throughout his career, Gareth Lewis has worked with prominent companies in the pharmaceutical industry, including Sanofi-Synthelabo and Synthelabo. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug formulation and delivery.
Collaborations
Gareth has collaborated with esteemed colleagues such as Maryvonne Chariot and Gérard Alaux. These partnerships have fostered a creative environment that has led to the development of groundbreaking pharmaceutical solutions.
Conclusion
Gareth Lewis's contributions to the field of pharmaceuticals through his innovative patents demonstrate his expertise and dedication to improving drug delivery systems. His work continues to influence the industry and enhance patient care.